The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
Abstract
BACKGROUND: Due to the success of antiretroviral therapy (ART), it is relevant to ask whether death rates in optimally treated HIV are higher than the general population. The objective was to compare mortality rates in well controlled HIV-infected adults in the SMART and ESPRIT clinical trials with the general population. METHODS: Non-IDUs aged 20-70 years from the continuous ART control arms of ESPRIT and SMART were included if the person had both low HIV plasma viral loads (≤400 copies/ml SMART, ≤500 copies/ml ESPRIT) and high CD4(+) T-cell counts (≥350 cells/μl) at any time in the past 6 months. Standardized mortality ratios (SMRs) were calculated by comparing death rates with the Human Mortality Database. RESULTS: Three thousand, two hundred and eighty individuals [665 (20%) women], median age 43 years, contributed 12,357 person-years of follow-up. Sixty-two deaths occurred during follow up. Commonest cause of death was cardiovascular disease (CVD) or sudden death (19, 31%), followed by non-AIDS malignancy (12, 19%). Only two deaths (3%) were AIDS-related. Mortality rate was increased compared with the general population with a CD4(+) cell count between 350 and 499 cells/μl [SMR 1.77, 95% confidence interval (CI) 1.17-2.55]. No evidence for increased mortality was seen with CD4(+) cell counts greater than 500 cells/μl (SMR 1.00, 95% CI 0.69-1.40). CONCLUSION: In HIV-infected individuals on ART, with a recent undetectable viral load, who maintained or had recovery of CD4(+) cell counts to at least 500 cells/μl, we identified no evidence for a raised risk of death compared with the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.721 · Cited by 1,255 · cited 1×
“infected people tend to be more likely to be smokers than in the general population [13,14] and have other risk behaviours that impact on health such as excess alcohol intake [15] and poorer psychological health [16,17], confounding that could have resulted in a bias in either direction.”
BackgroundFriis-Møller, N., Weber, R., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Mateu, S., Law, M., et al. (2003) · AIDS · doi:10.1097/00002030-200305230-00010 · Cited by 1,077
Self-citationMarkers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Neuhaus, J., Jacobs, Jr., Baker, J. V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L. H., Pett, S. L., Ristola, M., Ross, M. J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652749 · Cited by 869
Inflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity
De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.055 · Cited by 492
Projected life expectancy of people with HIV according to timing of diagnosis
Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N. (2012) · AIDS · doi:10.1097/qad.0b013e32834dcec9 · Cited by 443
Self-citationGalvan, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Longshore, D., Morton, S. C., Orlando, M., & Shapiro, M. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.179 · Cited by 438
Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C. L., Nachega, J. B., Dybul, M., & Hogg, R. S. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-4-201108160-00358 · Cited by 415
Moore, R. D., & Keruly, J. C. (2007) · Clinical Infectious Diseases · doi:10.1086/510746 · Cited by 415
Lewden, C., Chêne, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., Pellegrin, J.-L., Katlama, C., Dabis, F., & Leport, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318134257a · Cited by 402
van Sighem, A., Gras, L., Reiss, P., Brinkman, K., & de Wolf, F. (2010) · AIDS · doi:10.1097/qad.0b013e32833a3946 · Cited by 398
May, M., Gompels, M., Delpech, V., Porter, K., Post, F., Johnson, M., Dunn, D., Palfreeman, A., Gilson, R., Gazzard, B., et al. (2011) · BMJ · doi:10.1136/bmj.d6016 · Cited by 363
Self-citationViral Hepatitis in HIV Infection
Koziel, M. J., & Peters, M. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065142 · Cited by 322
The role of HIV in serious diseases other than AIDS.
Phillips, A. N., Neaton, J., & Lundgren, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283174636 · Cited by 269
Self-citationThe Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden, C., Bouteloup, V., De Wit, S., Sabin, C., Mocroft, A., Wasmuth, J. C., van Sighem, A., Kirk, O., Obel, N., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr164 · Cited by 252
Brinkhof, M. W. G., Boulle, A., Weigel, R., Messou, E., Mathers, C., Orrell, C., Dabis, F., Pascoe, M., Egger, M., & (IeDEA), F. T. I. E. D. T. E. A. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000066 · Cited by 204
The Antiretroviral Therapy Cohort Collaboration (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp306 · Cited by 200
Reluctance to be tested for HIV
Knussen, C., McDaid, L. M., & Flowers, P. (2011) · ResearchOnline · Cited by 187
The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients
Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. G. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200403010-00006 · Cited by 161
Correlates of Lending Needles/Syringes Among HIV-Seropositive Injection Drug Users
Metsch, L. R., Pereyra, M., Purcell, D. W., Latkin, C. A., Malow, R., Gómez, C. A., & Latka, M. H. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181576818 · Cited by 158
Babiker, A. G., Emery, S., Fätkenheuer, G., Gordin, F. M., Grund, B., Lundgren, J. D., Neaton, J. D., Pett, S. L., Phillips, A. N., Touloumi, G., et al. (2012) · Clinical Trials · doi:10.1177/1740774512440342 · Cited by 129
Self-citationKeiser, O., Taffé, P., Zwahlen, M., Battegay, M., Bernasconi, E., Weber, R. K., & Rickenbach, M. (2004) · AIDS · doi:10.1097/00002030-200409030-00013 · Cited by 89
The Evaluation of Subcutaneous Proleukin® (interleukin-2) in a Randomized International Trial
Emery, S., Abrams, D. I., Cooper, D. A., Darbyshire, J. H., Lane, H. C., Lundgren, J. D., & Neaton, J. D. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00179-9 · Cited by 86
The HIV epidemic among individuals with mental illness in the United States
Weiser, S. D., Wolfe, W. R., & Bangsberg, D. R. (2004) · Current HIV/AIDS Reports · doi:10.1007/s11904-004-0029-4 · Cited by 48
The antiretroviral therapy cohort collaboration (ART-CC) (2009) · AIDS · doi:10.1097/qad.0b013e3283305a00 · Cited by 44
Bénard, A., Tessier, J. F., Rambeloarisoa, J., Bonnet, F., Fossoux, H., Neau, D., Dutronc, H., Lazaro, E., Dabis, F., & Chêne, G. (2006) · PubMed · Cited by 42
Cited by
Antiretroviral therapy for the prevention of HIV-1 transmission.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600693 · Cited by 1,700
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
Serrano-Villar, S., Sainz, T., Lee, S. A., Hunt, P. W., Sinclair, E., Shacklett, B. L., Ferre, A. L., Hayes, T. L., Somsouk, M., Hsue, P. Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004078 · Cited by 611
Self-citationMay, M. T., Gompels, M., Delpech, V., Porter, K., Orkin, C., Kegg, S., Hay, P., Johnson, M., Palfreeman, A., Gilson, R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000243 · Cited by 593
Self-citation
Metadata
- Authors
- Rodger, A. J., Lodwick, R., Schechter, M., Deeks, S., Amin, J., Gilson, R., Paredes, R., Bakowska, E., Engsig, F. N., & Phillips, A.
- Venue
- AIDS
- Published
- 2013-03-27
- Volume
- 27
- Issue
- 6
- Pages
- 973-979
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2014171916
- Cited by
- 372
- References
- 26
- FWCI
- 36.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.